XML 57 R36.htm IDEA: XBRL DOCUMENT v3.25.1
Business Segment Information (Tables)
12 Months Ended
Mar. 31, 2025
Segment Reporting [Abstract]  
Summary of Disaggregated Expense

In addition to the significant expense categories included within Consolidated Net Loss presented in the Company’s Consolidated Statements of Operations and Other Comprehensive Loss, see below for disaggregated expense amounts for the years ended March 31, 2025 and 2024 (in thousands):

 

 

Year Ended

 

 

Year Ended

 

 

March 31, 2025

 

 

March 31, 2024

 

Revenue

 

 

 

 

 

    Royalty revenue

$

119

 

 

$

109

 

    Product revenue

 

25

 

 

 

 

Total revenue

 

144

 

 

 

109

 

Operating expenses

 

 

 

 

 

    Cost of revenues

 

5

 

 

 

 

    Research and development (a) (b)

 

4,712

 

 

 

5,133

 

    Selling, general, and administrative expenses (a)(b)

 

7,245

 

 

 

8,274

 

    Non-cash stock-based compensation (see Note 7)

 

532

 

 

 

1,508

 

    Depreciation and amortization (see Note 4)

 

266

 

 

 

280

 

Total operating expenses

$

12,760

 

 

$

15,195

 

Consolidated operating loss

$

(12,616

)

 

$

(15,086

)

 

(a) Stock-based compensation expense of $86,000 and $138,000 related to research and development and $446,000 and $1,370,000, related to selling, general, and administration have been excluded for the years ended March 31, 2025 and 2024, respectively.

(b) Depreciation and amortization expense of $227,000 related to research and development for each of the years ended March 31, 2025 and 2024. Depreciation and amortization expense of $39,000 and $53,000 related to selling, general, and administration have been excluded for the years ended March 31, 2025 and 2024, respectively.